MCKINNEY, Texas, Oct. 10, 2017 -- Independent Bank Group, Inc. (NASDAQ:IBTX), the holding company for Independent Bank, will hold a conference call to discuss third quarter results on Tuesday, October 24, 2017 at 8:30 am EDT. The related press release will be issued Monday, October 23, 2017 at 5:00 pm EDT.
Conference Call Details
The call can be accessed by calling 1-877-303-7611 and by identifying the conference ID number 96791274 or by identifying "Independent Bank Group Third Quarter 2017 Earnings Conference Call". The conference materials will also be available by accessing the Investor Relations page of our website, www.ibtx.com. A recording of the conference call and the conference materials will be available from October 24, 2017 through November 1, 2017 on our website.
About Independent Bank Group
Independent Bank Group, through its wholly owned subsidiary, Independent Bank, provides a wide range of relationship-driven commercial banking products and services tailored to meet the needs of businesses, professionals and individuals. Independent Bank Group operates 70 banking offices in four market regions located in the Dallas/Fort Worth, Austin and Houston, Texas and the Colorado Front Range areas.
Contacts:
Analysts/Investors:
Michelle Hickox
Executive Vice President and Chief Financial Officer
(972) 562-9004
[email protected]
Media:
Peggy Smolen
Marketing and Communications Director
(972) 562-9004
[email protected]


Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle
Vietnam’s EV Taxi Giant GSM Eyes Hong Kong IPO With $2–3 Billion Valuation
Lockheed Martin Secures $92.8M AEGIS Sustainment Contract from U.S. Navy
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
L&F Tesla Battery Supply Deal Value Drops Sharply Amid EV Market Slowdown
Trump Administration Probes Corporate DEI Programs, Raising Questions for Google Stock
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Star Entertainment Leadership Shake-Up Deepens as CFO and COO Exit Amid Ongoing Restructuring
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
Lloyds Banking Group to Close Invoice Factoring Business by End of 2025 



